Issue 3/2002
Content (11 Articles)
Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEM
Takeshi Takahashi, Makiko Shimizu, Shiro Akinaga
A phase I study of the GM-CSF antagonist E21R
Ian N. Olver, Tim Hercus, Angel Lopez, Matthew Vadas, Andrew A. Somogyi, Ian Doyle, David J. Foster, Dorothy Keefe, Anne Taylor, Michael Brown, Bik L. To, Julie Cole, Trevor Rawling, Bronwyn Cambareri, Melinda Myers, Nancy Olszewski, Stan Bastiras, Carol Senn, Allan Hey, Meera Verma, Peter Wigley
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies
Apostolia-Maria Tsimberidou, Deborah Thomas, Susan O'Brien, Michael Andreeff, Razelle Kurzrock, Michael Keating, Maher Albitar, Hagop Kantarjian, Francis Giles
Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule
Lynn Feun, Manuel Modiano, King Lee, John Mao, Angela Marini, Niramol Savaraj, Patricia Plezia, Bijan Almassian, Elizabeth Colacino, Jessica Fischer, Susan MacDonald
Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide
Qi Ding, Philip Kestell, Bruce C. Baguley, Brian D. Palmer, James W. Paxton, George Muller, Lai-Ming Ching
Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate
Khalid Matin, Merrill J. Egorin, Michael F. Ballesteros, David C. Smith, Barry Lembersky, Roger S. Day, Candace S. Johnson, Donald L. Trump
A formula for predicting optimal dosage of nedaplatin based on renal function in adult cancer patients
T. Ishibashi, Y. Yano, T. Oguma
Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support
Meiyu Shen, Russell J. Schilder, Coleman Obasaju, James M. Gallo
In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells
Ralph Alderson, Shiva Gohari-Fritsch, Hendrik Olsen, Viktor Roschke, Courtney Vance, Kevin Connolly
Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin
Milly E. de Jonge, Ron A. Mathôt, Selma M. van Dam, Jos H. Beijnen, Sjoerd Rodenhuis
Stimulation of TNF-α production by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) – a novel immunomodulator with potential application in tumour immunotherapy
Witold Lasek, Tomasz Świtaj, Jacek Sieńko, Monika Kasprzycka, Grzegorz Basak, Piotr Mikłaszewicz, Małgorzata Maj, Dominika Nowis, Tomasz Grzela, Jakub Gołąb, Izabela Młynarczuk, Ahmad Jalili, Bożena Kamińska, Magdalena Dziembowska, Krzysztof Czajkowski, Maria Nowaczyk, Agata Górska, Zygmunt Kazimierczuk